Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to compare the antidepressant efficacy, safety, and tolerability of DVS-SR in subjects receiving daily doses of 50 mg or 100 mg of DVS-SR versus subjects receiving placebo.
Epistemonikos ID: 4c89be4463e8dae579458cfb0d02df5d18bbf42f
First added on: May 04, 2024